A collagen-like surface glycoprotein is a structural component of the Bacillus anthracis exosporium.

PubWeight™: 3.26‹?› | Rank: Top 1%

🔗 View Article (PMID 12100557)

Published in Mol Microbiol on July 01, 2002

Authors

Patricia Sylvestre1, Evelyne Couture-Tosi, Michèle Mock

Author Affiliations

1: Unité Toxines et Pathogénie Bactériennes (URA 2172, CNRS), Institut Pasteur, Paris, France.

Articles citing this

(truncated to the top 100)

The genome sequence of Bacillus cereus ATCC 10987 reveals metabolic adaptations and a large plasmid related to Bacillus anthracis pXO1. Nucleic Acids Res (2004) 3.62

Identification of the immunodominant protein and other proteins of the Bacillus anthracis exosporium. J Bacteriol (2003) 2.48

Proteomic analysis of the spore coats of Bacillus subtilis and Bacillus anthracis. J Bacteriol (2003) 2.34

Genes of Bacillus cereus and Bacillus anthracis encoding proteins of the exosporium. J Bacteriol (2003) 2.19

Formation and composition of the Bacillus anthracis endospore. J Bacteriol (2004) 2.12

Polymorphism in the collagen-like region of the Bacillus anthracis BclA protein leads to variation in exosporium filament length. J Bacteriol (2003) 1.99

Murine macrophages kill the vegetative form of Bacillus anthracis. Infect Immun (2005) 1.91

Orientation within the exosporium and structural stability of the collagen-like glycoprotein BclA of Bacillus anthracis. J Bacteriol (2005) 1.71

Characterization of the exosporium basal layer protein BxpB of Bacillus anthracis. J Bacteriol (2005) 1.52

Morphogenesis of bacillus spore surfaces. J Bacteriol (2003) 1.50

Detailed genomic analysis of the Wbeta and gamma phages infecting Bacillus anthracis: implications for evolution of environmental fitness and antibiotic resistance. J Bacteriol (2006) 1.46

The integrin Mac-1 (CR3) mediates internalization and directs Bacillus anthracis spores into professional phagocytes. Proc Natl Acad Sci U S A (2008) 1.44

Morphogenesis of the Bacillus anthracis spore. J Bacteriol (2006) 1.43

Contribution of ExsFA and ExsFB proteins to the localization of BclA on the spore surface and to the stability of the bacillus anthracis exosporium. J Bacteriol (2005) 1.42

A collagenous protective coat enables Metarhizium anisopliae to evade insect immune responses. Proc Natl Acad Sci U S A (2006) 1.38

The dynamic spore. Proc Natl Acad Sci U S A (2003) 1.33

Proteomic profiling and identification of immunodominant spore antigens of Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis. Appl Environ Microbiol (2006) 1.29

The ExsY protein is required for complete formation of the exosporium of Bacillus anthracis. J Bacteriol (2006) 1.25

The genome and variation of Bacillus anthracis. Mol Aspects Med (2009) 1.23

Identifying experimental surrogates for Bacillus anthracis spores: a review. Investig Genet (2010) 1.23

Surface layers of Clostridium difficile endospores. J Bacteriol (2011) 1.22

Bacillus anthracis exosporium protein BclA affects spore germination, interaction with extracellular matrix proteins, and hydrophobicity. Infect Immun (2007) 1.22

Anthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxin. Med Immunol (2005) 1.22

Identification of the first prokaryotic collagen sequence motif that mediates binding to human collagen receptors, integrins alpha2beta1 and alpha11beta1. J Biol Chem (2008) 1.22

Self-association of streptococcus pyogenes collagen-like constructs into higher order structures. Protein Sci (2009) 1.21

Influence of pilin glycosylation on Pseudomonas aeruginosa 1244 pilus function. Infect Immun (2005) 1.20

Detection of Bacillus anthracis spore germination in vivo by bioluminescence imaging. Infect Immun (2008) 1.19

Bacillus anthracis spores of the bclA mutant exhibit increased adherence to epithelial cells, fibroblasts, and endothelial cells but not to macrophages. Infect Immun (2007) 1.18

Importance of nitric oxide synthase in the control of infection by Bacillus anthracis. Infect Immun (2006) 1.18

Identification of the Bacillus anthracis (gamma) phage receptor. J Bacteriol (2005) 1.17

Deglycosylation of glycoproteins with trifluoromethanesulphonic acid: elucidation of molecular structure and function. Biochem J (2003) 1.16

Sequencing Bacillus anthracis typing phages gamma and cherry reveals a common ancestry. J Bacteriol (2006) 1.14

Anthrose biosynthetic operon of Bacillus anthracis. J Bacteriol (2008) 1.14

CapE, a 47-amino-acid peptide, is necessary for Bacillus anthracis polyglutamate capsule synthesis. J Bacteriol (2005) 1.13

Search for Bacillus anthracis potential vaccine candidates by a functional genomic-serologic screen. Infect Immun (2006) 1.12

Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens. Infect Immun (2003) 1.11

The ExsA protein of Bacillus cereus is required for assembly of coat and exosporium onto the spore surface. J Bacteriol (2005) 1.10

Anthrax vaccination strategies. Mol Aspects Med (2009) 1.08

Surface architecture of endospores of the Bacillus cereus/anthracis/thuringiensis family at the subnanometer scale. Proc Natl Acad Sci U S A (2011) 1.07

ExsY and CotY are required for the correct assembly of the exosporium and spore coat of Bacillus cereus. J Bacteriol (2006) 1.04

Fully virulent Bacillus anthracis does not require the immunodominant protein BclA for pathogenesis. Infect Immun (2006) 1.04

Identification of a second collagen-like glycoprotein produced by Bacillus anthracis and demonstration of associated spore-specific sugars. J Bacteriol (2005) 1.03

The co-dependence of BxpB/ExsFA and BclA for proper incorporation into the exosporium of Bacillus anthracis. Mol Microbiol (2011) 1.02

A Streptococcus pyogenes derived collagen-like protein as a non-cytotoxic and non-immunogenic cross-linkable biomaterial. Biomaterials (2010) 1.02

Pseudomonas aeruginosa 1244 pilin glycosylation: glycan substrate recognition. J Bacteriol (2006) 1.01

Role of Bacillus anthracis spore structures in macrophage cytokine responses. Infect Immun (2007) 1.01

Sequence motifs and proteolytic cleavage of the collagen-like glycoprotein BclA required for its attachment to the exosporium of Bacillus anthracis. J Bacteriol (2009) 1.00

Expanding the family of collagen proteins: recombinant bacterial collagens of varying composition form triple-helices of similar stability. Biomacromolecules (2010) 1.00

Roles of the Bacillus anthracis spore protein ExsK in exosporium maturation and germination. J Bacteriol (2009) 1.00

In vivo demonstration and quantification of intracellular Bacillus anthracis in lung epithelial cells. Infect Immun (2008) 0.99

The Clostridium difficile exosporium cysteine (CdeC)-rich protein is required for exosporium morphogenesis and coat assembly. J Bacteriol (2013) 0.98

Characterization of the enzymes encoded by the anthrose biosynthetic operon of Bacillus anthracis. J Bacteriol (2010) 0.98

Localization and assembly of proteins comprising the outer structures of the Bacillus anthracis spore. Microbiology (2009) 0.97

The spore-specific alanine racemase of Bacillus anthracis and its role in suppressing germination during spore development. J Bacteriol (2008) 0.97

The contribution of gC1qR/p33 in infection and inflammation. Immunobiology (2007) 0.97

Synthesis of the antigenic tetrasaccharide side chain from the major glycoprotein of Bacillus anthracis exosporium. J Org Chem (2007) 0.96

The C1q family of proteins: insights into the emerging non-traditional functions. Front Immunol (2012) 0.95

The BclB glycoprotein of Bacillus anthracis is involved in exosporium integrity. J Bacteriol (2007) 0.94

An engineered alpha1 integrin-binding collagenous sequence. J Biol Chem (2010) 0.92

The Exosporium Layer of Bacterial Spores: a Connection to the Environment and the Infected Host. Microbiol Mol Biol Rev (2015) 0.92

Development of antibodies against anthrose tetrasaccharide for specific detection of Bacillus anthracis spores. Clin Vaccine Immunol (2009) 0.91

Recombinant Bacillus anthracis spore proteins enhance protection of mice primed with suboptimal amounts of protective antigen. Vaccine (2008) 0.91

Identification and classification of bcl genes and proteins of Bacillus cereus group organisms and their application in Bacillus anthracis detection and fingerprinting. Appl Environ Microbiol (2009) 0.91

Receptor mimicry as novel therapeutic treatment for biothreat agents. Bioeng Bugs (2011) 0.91

Recombinant exosporium protein BclA of Bacillus anthracis is effective as a booster for mice primed with suboptimal amounts of protective antigen. Infect Immun (2007) 0.90

ExsB, an unusually highly phosphorylated protein required for the stable attachment of the exosporium of Bacillus anthracis. Mol Microbiol (2010) 0.90

Bacterial collagen-like proteins that form triple-helical structures. J Struct Biol (2014) 0.89

Bacillus anthracis interacts with plasmin(ogen) to evade C3b-dependent innate immunity. PLoS One (2011) 0.88

A novel spore protein, ExsM, regulates formation of the exosporium in Bacillus cereus and Bacillus anthracis and affects spore size and shape. J Bacteriol (2010) 0.87

Current physical and SDS extraction methods do not efficiently remove exosporium proteins from Bacillus anthracis spores. J Microbiol Methods (2011) 0.87

Retracted An unusual mechanism of isopeptide bond formation attaches the collagenlike glycoprotein BclA to the exosporium of Bacillus anthracis. MBio (2011) 0.86

Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax. Infect Immun (2008) 0.86

B cell development in GALT: role of bacterial superantigen-like molecules. J Immunol (2010) 0.86

Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen. Gut Microbes (2014) 0.86

Collagen-like proteins in pathogenic E. coli strains. PLoS One (2012) 0.85

Existence of separate domains in lysin PlyG for recognizing Bacillus anthracis spores and vegetative cells. Antimicrob Agents Chemother (2012) 0.85

Cryo-EM analysis of the organization of BclA and BxpB in the Bacillus anthracis exosporium. J Struct Biol (2014) 0.85

Identification of the immunogenic spore and vegetative proteins of Bacillus anthracis vaccine strain A16R. PLoS One (2013) 0.84

Fast and sensitive detection of Bacillus anthracis spores by immunoassay. Appl Environ Microbiol (2012) 0.84

Role played by exosporium glycoproteins in the surface properties of Bacillus cereus spores and in their adhesion to stainless steel. Appl Environ Microbiol (2011) 0.84

Assembly of the BclB glycoprotein into the exosporium and evidence for its role in the formation of the exosporium 'cap' structure in Bacillus anthracis. Mol Microbiol (2012) 0.84

Microbicidal power of alpha radiation in sterilizing germinating Bacillus anthracis spores. Antimicrob Agents Chemother (2013) 0.83

Development and implementation of a single-chain Fv antibody for specific detection of Bacillus anthracis spores. Appl Environ Microbiol (2007) 0.82

Crystal structure of prolyl 4-hydroxylase from Bacillus anthracis. Biochemistry (2010) 0.82

A simple cost-effective methodology for large-scale purification of recombinant non-animal collagens. Appl Microbiol Biotechnol (2014) 0.82

Identification of the UDP-N-acetylglucosamine 4-epimerase involved in exosporium protein glycosylation in Bacillus anthracis. J Bacteriol (2009) 0.81

Collagen-like proteins (ClpA, ClpB, ClpC, and ClpD) are required for biofilm formation and adhesion to plant roots by Bacillus amyloliquefaciens FZB42. PLoS One (2015) 0.81

YwdL in Bacillus cereus: its role in germination and exosporium structure. PLoS One (2011) 0.80

Plasmid-encoded genes influence exosporium assembly and morphology in Bacillus megaterium QM B1551 spores. FEMS Microbiol Lett (2015) 0.79

Identification and characterization of glycoproteins on the spore surface of Clostridium difficile. J Bacteriol (2014) 0.79

Characterization of a multi-component anthrax vaccine designed to target the initial stages of infection as well as toxaemia. J Med Microbiol (2012) 0.79

Aspergillus collagen-like genes (acl): identification, sequence polymorphism, and assessment for PCR-based pathogen detection. Appl Environ Microbiol (2013) 0.79

The exosporium of B. cereus contains a binding site for gC1qR/p33: implication in spore attachment and/or entry. Adv Exp Med Biol (2007) 0.78

Localization and assembly of the novel exosporium protein BetA of Bacillus anthracis. J Bacteriol (2011) 0.78

Immunization of mice with formalin-inactivated spores from avirulent Bacillus cereus strains provides significant protection from challenge with Bacillus anthracis Ames. Clin Vaccine Immunol (2012) 0.78

Clostridium sordellii genome analysis reveals plasmid localized toxin genes encoded within pathogenicity loci. BMC Genomics (2015) 0.78

Sporulation Temperature Reveals a Requirement for CotE in the Assembly of both the Coat and Exosporium Layers of Bacillus cereus Spores. Appl Environ Microbiol (2015) 0.77

The Regulation of Exosporium-Related Genes in Bacillus thuringiensis. Sci Rep (2016) 0.77

Glycosylation of BclA Glycoprotein from Bacillus cereus and Bacillus anthracis Exosporium Is Domain-specific. J Biol Chem (2016) 0.77

Synthesis of bioactive microcapsules using a microfluidic device. Sensors (Basel) (2012) 0.77

Articles by these authors

Diversity among French Bacillus anthracis isolates. J Clin Microbiol (2002) 2.41

Polymorphism in the collagen-like region of the Bacillus anthracis BclA protein leads to variation in exosporium filament length. J Bacteriol (2003) 1.99

Primary involvement of pharynx and peyer's patch in inhalational and intestinal anthrax. PLoS Pathog (2007) 1.70

Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies. Infect Immun (2004) 1.64

Anthrax spores make an essential contribution to vaccine efficacy. Infect Immun (2002) 1.62

Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells. J Immunol (2005) 1.59

Contribution of ExsFA and ExsFB proteins to the localization of BclA on the spore surface and to the stability of the bacillus anthracis exosporium. J Bacteriol (2005) 1.42

Structure of the exosporium and sublayers of spores of the Bacillus cereus family revealed by electron crystallography. Mol Microbiol (2008) 1.35

Distinct mutations in PlcR explain why some strains of the Bacillus cereus group are nonhemolytic. J Bacteriol (2004) 1.32

A plasmid-encoded regulator couples the synthesis of toxins and surface structures in Bacillus anthracis. Mol Microbiol (2003) 1.30

Screening inhibitors of anthrax lethal factor. Nature (2002) 1.30

Developmental switch of S-layer protein synthesis in Bacillus anthracis. Mol Microbiol (2002) 1.23

Identification of the Bacillus anthracis (gamma) phage receptor. J Bacteriol (2005) 1.17

Noninvasive imaging technologies reveal edema toxin as a key virulence factor in anthrax. Am J Pathol (2011) 1.16

Cutting Edge: IFN-gamma-producing CD4 T lymphocytes mediate spore-induced immunity to capsulated Bacillus anthracis. J Immunol (2007) 1.14

The spore differentiation pathway in the enteric pathogen Clostridium difficile. PLoS Genet (2013) 1.14

CapE, a 47-amino-acid peptide, is necessary for Bacillus anthracis polyglutamate capsule synthesis. J Bacteriol (2005) 1.13

Extended and global phylogenetic view of the Bacillus cereus group population by combination of MLST, AFLP, and MLEE genotyping data. Food Microbiol (2010) 1.05

Inactivation of the spirochete recA gene results in a mutant with low viability and irregular nucleoid morphology. J Bacteriol (2002) 1.03

In vivo protective role of human group IIa phospholipase A2 against experimental anthrax. J Immunol (2005) 1.02

Murine splenocytes produce inflammatory cytokines in a MyD88-dependent response to Bacillus anthracis spores. Cell Microbiol (2006) 1.01

Regulatory networks for virulence and persistence of Bacillus anthracis. Curr Opin Microbiol (2006) 1.01

Potent inhibitors of anthrax lethal factor from green tea. EMBO Rep (2004) 1.00

Inhaled non-capsulated Bacillus anthracis in A/J mice: nasopharynx and alveolar space as dual portals of entry, delayed dissemination, and specific organ targeting. Microbes Infect (2008) 0.99

Noncapsulated toxinogenic Bacillus anthracis presents a specific growth and dissemination pattern in naive and protective antigen-immune mice. Infect Immun (2007) 0.92

Characterization of Acp, a peptidoglycan hydrolase of Clostridium perfringens with N-acetylglucosaminidase activity that is implicated in cell separation and stress-induced autolysis. J Bacteriol (2010) 0.91

In vivo Bacillus anthracis gene expression requires PagR as an intermediate effector of the AtxA signalling cascade. Int J Med Microbiol (2004) 0.90

In vivo germination of Bacillus anthracis spores during murine cutaneous infection. J Infect Dis (2012) 0.87

Bacillus anthracis: balancing innocent research with dual-use potential. Int J Med Microbiol (2008) 0.87

Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax. Infect Immun (2008) 0.86

Variation in rRNA operon number as revealed by ribotyping of Bacillus anthracis strains. Res Microbiol (2002) 0.84

Fast and sensitive detection of Bacillus anthracis spores by immunoassay. Appl Environ Microbiol (2012) 0.84

Distinct functions of polysaccharide deacetylases in cell shape, neutral polysaccharide synthesis and virulence of Bacillus anthracis. Mol Microbiol (2013) 0.82

The International Bacillus anthracis, B. cereus, and B. thuringiensis Conference, "Bacillus-ACT05". J Bacteriol (2006) 0.81

Cell-wall preparation containing poly-γ-D-glutamate covalently linked to peptidoglycan, a straightforward extractable molecule, protects mice against experimental anthrax infection. Vaccine (2012) 0.77

Of spore opsonization and passive protection against anthrax. Microbiology (2007) 0.76

Carbohydrate metabolism differences between subgroup A1 and B2 strains of Bacillus anthracis as assessed by comparative genomics and functional genetics. Appl Environ Microbiol (2009) 0.75

Editorial. Mol Aspects Med (2009) 0.75

[Anthrax revisited: Bacillus anthracis toxins as novel actors of immune escape?]. Bull Acad Natl Med (2006) 0.75